Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?
出版年份 2021 全文链接
标题
Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?
作者
关键词
-
出版物
CLINICAL RHEUMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-19
DOI
10.1007/s10067-021-05757-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Osteosarcopenia: epidemiology, diagnosis, and treatment—facts and numbers
- (2020) Ben Kirk et al. Journal of Cachexia Sarcopenia and Muscle
- Osteosarcopenia: where osteoporosis and sarcopenia collide
- (2020) Michael A Clynes et al. RHEUMATOLOGY
- Effect of Denosumab on Falls, Muscle Strength, and Function in Community‐Dwelling Older Adults
- (2019) Steven Phu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis
- (2018) Albrecht Werner Popp et al. CALCIFIED TISSUE INTERNATIONAL
- Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy
- (2018) Sébastien S. Dufresne et al. Acta Neuropathologica Communications
- OUP accepted manuscript
- (2018) AGE AND AGEING
- Osteosarcopenia: where bone, muscle, and fat collide
- (2017) H. P. Hirschfeld et al. OSTEOPOROSIS INTERNATIONAL
- Differentiating Sarcopenia and Cachexia Among Patients With Cancer
- (2016) Sarah J. Peterson et al. NUTRITION IN CLINICAL PRACTICE
- Osteoprotegerin Protects against Muscular Dystrophy
- (2015) Sébastien S. Dufresne et al. AMERICAN JOURNAL OF PATHOLOGY
- Use of alfacalcidol in osteoporotic patients with low muscle mass might increase muscle mass: An investigation using a patient database
- (2014) Sadayuki Ito et al. Geriatrics & Gerontology International
- Differential impact of the Bisphosphonate Alendronate on undifferentiated and terminally differentiated human myogenic cells
- (2013) Kosuke Shiomi et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women
- (2013) Joo Hyun Park et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Is vitamin D a determinant of muscle mass and strength?
- (2011) Isabel Marantes et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Alendronate improves QOL of postmenopausal women with osteoporosis
- (2010) Hisaya Kawate Clinical Interventions in Aging
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats
- (2008) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started